Summary

Market Overview
Respiratory diagnosis refers to the clinical examination of lung function and associated processes. It encompasses a variety of mechanical, radiological, and molecular diagnostic tests for the detection of asthma, COPD, lung cancer, bronchitis, and pulmonary fibrosis. It uses methods such as Spirometry, oximetry, transcutaneous CO2 monitoring, sniff nasal inspiratory pressure (SNIP), chest X-ray, and computed tomography (CT) scan. Sleep studies are used to identify and analyze the occurrence of sleep apnea and nocturnal hypoventilation in some cases. The global market for respiratory diagnostics has a lot of room for expansion. In the near future, the entry of new companies in the market is anticipated to heighten competition. To keep ahead of the competition, leading companies are likely to focus on product innovation and technical developments.

Respiratory Diagnostics Market: Key Players
Philips Healthcare

Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis

Abbott Laboratories
Biomerieux
Becton Dickinson
Thermo Fisher Scientific
Alere Inc.
Seegene Inc.
3M
Bio-Rad Laboratories
SDI Diagnostics
COSMED
Masimo Corporation


Growth Factor
Growing occurrence of respiratory diseases
COPD and other serious respiratory illnesses, such as lung cancer, are on the rise due to an increase in smokers and alcohol intake, as well as sedentary living habits and stressful routines. Furthermore, several technical advancements in respiratory diagnostic tests, such as the use of the Internet of Things (IoT) and Artificial Intelligence (AI) for COPD diagnosis and outpatient care, are boosting market expansion. The market for respiratory diagnostics is also being driven by an increase in demand for respiratory diagnostics devices in various privately-owned hospitals and healthcare centers, as well as efforts by both government and non-governmental organizations (NGO) to make quality healthcare facilities available to all.

Technological Advancements
The market is being driven by technological advancements and innovation in the respiratory diagnostic system. The use of cutting-edge technologies such as monitoring systems and electronic inhalers is helping to drive growth. Furthermore, rising treatment awareness in both developed and developing nations is adding to the market's growth throughout the forecast period.

Segmentation
By Product and Service Type:
Instruments and Services
Assays and Reagents
Services and Software
By Test Type:
Mechanical Tests
Obstructive Sleep Apnoea (OSA) Diagnostic Tests
Imaging Tests
Traditional Diagnostic Tests
Molecular Diagnostic Tests
Others
By Disease:
Tuberculosis
Asthma
Chronic Obstructive Pulmonary Disease (COPD)
Lung Cancer
Others
By End-User:
Hospitals
Clinics
Reference and Clinical Laboratories
Others
Respiratory Diagnostics Market Dynamics
Respiratory Diagnostics Market Size
Supply & Demand
Current Trends/Issues/Challenges
Competition & Companies Involved in the Market
Value Chain of the Market
Market Drivers and Restraints


Recent News Related to Market
In June 2020, GE Healthcare announced the Thoracic Care Suite which includes eight artificial intelligence (AI) algorithms that allow chest X-rays to detect anomalies, such as pneumonia, a symptom linked to COVID-19. This new product, introduced by the firm during the expansion of COVID-19, has increased the firm's market reputation.

In May 2020, Philips and Masimo formed a cooperation. This collaboration sought to integrate Masimo's measuring technology into certain Intellivue MX-Series multi-parameter monitors, allowing doctors to analyse ventilation status and cerebral oximetry more easily.



The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
COVID-19 pre and post business impact analysis
Detailed overview of the parent market
Changing market dynamics in the industry
In-depth market segmentation
What is the Respiratory Diagnostics Market growth?
Which segment accounted for the largest Respiratory Diagnostics Market share?
Who are the key players in the Respiratory Diagnostics Market?
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint


Note: Although care has been taken to maintain the highest levels of accuracy in Fatpos Global’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

ページTOPに戻る

Table of Contents

Contents
1. Executive Summary
2. Global Respiratory Diagnostics Market
2.1. Product Overview
2.2. Market Definition
2.3. Segmentation
2.4. Assumptions and Acronyms
3. Research Methodology
3.1. Research Objectives
3.2. Primary Research
3.3. Secondary Research
3.4. Forecast Model
3.5. Market Size Estimation
4. Average Pricing Analysis
5. Macro-Economic Indicators
6. Market Dynamics
6.1. Growth Drivers
6.2. Restraints
6.3. Opportunity
6.4. Trends
7. Correlation & Regression Analysis
7.1. Correlation Matrix
7.2. Regression Matrix
8. Recent Development, Policies & Regulatory Landscape
9. Risk Analysis
9.1. Demand Risk Analysis
9.2. Supply Risk Analysis
10. Global Respiratory Diagnostics Market Analysis
10.1. Porters Five Forces
10.1.1. Threat of New Entrants
10.1.2. Bargaining Power of Suppliers
10.1.3. Threat of Substitutes
10.1.4. Rivalry
10.2. PEST Analysis
10.2.1. Political
10.2.2. Economic
10.2.3. Social
10.2.4. Technological
11. Global Respiratory Diagnostics market
11.1. Market Size & forecast, 2020A-2030F
11.1.1. By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
11.1.2. By Volume (Million Units) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12. Global Respiratory Diagnostics Market: Market Segmentation
12.1. By Regions
12.1.1. North America:(U.S. and Canada), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.2. Europe: (Germany, UK, France, Italy, Spain, Russia and Rest of Europe), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.3. Asia-Pacific: (China, India, Japan, South Korea, Australia and Rest of Asia Pacific), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.4. Middle East and Africa: (Saudi Arabia, South Africa, UAE and rest of Middle East and Africa), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.1.5. Latin America (Brazil, Mexico and Argentina, Rest of South America), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2. By Product and Service Type: Market Share (2020-2030F)
12.2.1. Instruments and Services, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.2.2. Services and Software, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3. By Test Type: Market Share (2020-2030F)
12.3.1. Mechanical Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.2. Obstructive Sleep Apnoea (OSA) Diagnostic Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.3. Imaging Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.4. Traditional Diagnostic Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.5. Molecular Diagnostic Tests, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.3.6. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4. By Disease: Market Share (2020-2030F)
12.4.1. Tuberculosis, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.2. Asthma, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.3. Chronic Obstructive Pulmonary Disease (COPD), By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.4. Lung Cancer, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.4.5. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5. By End user: Market Share (2020-2030F)
12.5.1. Hospitals, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.2. Clinics, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.3. Reference and Clinical Laboratories, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
12.5.4. Others, By Value (USD Million) 2020-2030F; Y-o-Y Growth (%) 2021-2030F
13. Company Profile
13.1. Philips Healthcare
13.1.1. Company Overview
13.1.2. Company Total Revenue (Financials)
13.1.3. Market Potential
13.1.4. Global Presence
13.1.5. Key Performance Indicators
13.1.6. SWOT Analysis
13.1.7. Product Launch
13.2. Abbott Laboratories
13.3. Biomerieux
13.4. Becton Dickinson
13.5. Thermo Fisher Scientific
13.6. Alere Inc.
13.7. Seegene Inc.
13.8. 3M
13.9. Bio-Rad Laboratories
13.10. SDI Diagnostics
13.11. COSMED
13.12. Masimo Corporation
13.13. Other Prominent Players
Consultant Recommendation
**The above-given segmentations and companies could be subjected to further modification based on in-depth feasibility studies conducted for the final deliverable.